MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Press releases

Displaying 11..20 of 135 - per page Previous page Next page
Order by
Worldwide Business Research and Pharmalicensing jointly awarded Endo Pharmaceuticals and Vernalis the BioBusiness Network Innovative Partnership 2004 award at BioBusiness Network 2004 in Geneva, Switzerland More
STALLERGENES SA and CMC Biopharmaceuticals A/S announce today that they have entered into an agreement for development and supply of recombinant Bet v 1 (rBet v 1) purified bulk More
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More
The report, by Pharmalicensing founder Steve Poile and Head of Publishing Suzanne Elvidge, is an in-depth review of licensing structures and strategies for discovery and preclinical deals, supported with case studies and deals data analysis. More
Excellence Recognized for Pharmalicensing's Industry Information, Company and Technology Profiles, and Impressive Number of Deals Done More
Galenix today announced that it has out-licensed six drug delivery technologies to DSM Pharmaceutical Products, Parsippany, USA. Galenix and DSM have also agreed on a manufacturing alliance, where DSM will be the preferred commercial scale manufacturing More
AGI Therapeutics plc, announced its admission to trading on AIM and IEX in a €42.5 Million (£29.2 million) Placing on 27 February 2006, which was arranged by Davy. More
Displaying 11..20 of 135 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
GenericsWeb
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us